Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Comment by wizzdumbon Jun 07, 2022 11:54am
193 Views
Post# 34737211

RE:RE:RE:RE:RE:BloomBurton initiated coverage with a BUY yesterday

RE:RE:RE:RE:RE:BloomBurton initiated coverage with a BUY yesterday Well I'm not sure they could have possibly been more conservative in their analysis. The fact that they start out calling MBX a COVID play wasn't positive. Very thorough but make some questionable assumptions. Saying all that they still come out with this being pretty much a for sure double so guess that's a positive. It's very clear that they are giving management absolutely zero credibility and that as I've said for some time Q4 is going to be chance for management to finally show everyone definitively that they aren't living in La La land. They better deliver without excuses or we will continue to wallow at these current levels. A bit disappointed we still haven't seen a single partnership announcement since Q4 starts in 3 weeks. 
<< Previous
Bullboard Posts
Next >>